Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.5800 (-7.36%) ($29.0000 - $32.2000) on Wed. Mar. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.36% (three month average) | RSI | 66 | Latest Price | $29.5800(-7.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -3.9% a day on average for past five trading days. | Weekly Trend | IOVA advances 7.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(51%) XBI(50%) ARKG(49%) IWO(46%) ARKK(44%) | Factors Impacting IOVA price | IOVA will decline at least -2.68% in a week (0% probabilities). VIXM(-30%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.68% (StdDev 5.36%) | Hourly BBV | 0 () | Intraday Trend | -4.9% | | | |
|
Resistance Level | $30.44 | 5 Day Moving Average | $33.76(-12.38%) | 10 Day Moving Average | $34.24(-13.61%) | 20 Day Moving Average | $30.44(-2.83%) | To recent high | -23.9% | To recent low | 36.7% | Market Cap | $4.332b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |